A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors.
Saved in:
| Title: | A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors. |
|---|---|
| Authors: | Karasic TB; University of Pennsylvania, Philadelphia, Pennsylvania, USA. thomas.karasic@pennmedicine.upenn.edu., Chiorean EG; University of Washington, Seattle, Washington, USA., Sebti SM; H. Lee Moffitt Cancer Care and Research Center, Tampa, FL, USA., O'Dwyer PJ; University of Pennsylvania, Philadelphia, Pennsylvania, USA. |
| Source: | Targeted oncology [Target Oncol] 2019 Oct; Vol. 14 (5), pp. 613-618. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1776-260X |
|---|---|
| DOI: | 10.1007/s11523-019-00661-5 |
